Ashwin Chetty
he/him/his
About
Research
Publications
Featured Publications
Proportion of Obesity-Related Conditions Attributable to Obesity and Overweight in US Youth.
Chetty AK, Chen AS, Hajduk AM, Sharifi M, Nugent JT. Proportion of Obesity-Related Conditions Attributable to Obesity and Overweight in US Youth. JAMA Pediatr 2025 PMID: 40853652, DOI: 10.1001/jamapediatrics.2025.2716.Peer-Reviewed Original ResearchGlucagon-Like Peptide-1 Receptor Agonist Eligibility Among US Adolescents and Young Adults
Chetty A, Sharifi M, Nugent J. Glucagon-Like Peptide-1 Receptor Agonist Eligibility Among US Adolescents and Young Adults. JAMA Pediatrics 2025, 179 PMID: 40758363, PMCID: PMC12322816, DOI: 10.1001/jamapediatrics.2025.2308.Peer-Reviewed Original ResearchOnline Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists
Chetty A, Chillakanti M, Ramachandran R, Ross J, Chen A. Online Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists. JAMA Health Forum 2025, 6: e245018. PMID: 39820389, PMCID: PMC11742527, DOI: 10.1001/jamahealthforum.2024.5018.Peer-Reviewed Original Research
2025
Compounded GLP-1 Receptor Agonists: Opportunity for Compassionate Conversation
Chetty A, Chen A. Compounded GLP-1 Receptor Agonists: Opportunity for Compassionate Conversation. Journal Of General Internal Medicine 2025, 1-2. PMID: 40696223, DOI: 10.1007/s11606-025-09765-3.Commentaries, Editorials and LettersImpact of Preoperative LDL Level on Lower Extremity Revascularization Outcomes
Carter W, Alappan U, Chetty A, Wells N, Alameddine D, Slade M, Possick S, Ochoa Chaar C. Impact of Preoperative LDL Level on Lower Extremity Revascularization Outcomes. Annals Of Vascular Surgery 2025, 122: 239-247. PMID: 40651525, DOI: 10.1016/j.avsg.2025.07.016.Peer-Reviewed Original ResearchLower extremity revascularizationPeripheral arterial diseaseRetrospective chart reviewProportion of patientsRetrospective chart review of patientsChart review of patientsLDL testingReview of patientsCox regression analysisAdverse cardiovascular eventsChronic limb-threatening ischemiaHybrid lower extremity revascularizationBurden of comorbiditiesAssociated with outcomeLimb-threatening ischemiaOld white maleBaseline LDLTertiary centerStatin useLipid testingCardiovascular eventsFollow-upLDL levelsLower LDLRevascularization outcomesPrevalence of Heart Failure With Type 1 Diabetes and Type 2 Diabetes Among US Adults
Chetty A, Chen A. Prevalence of Heart Failure With Type 1 Diabetes and Type 2 Diabetes Among US Adults. Endocrine Practice 2025, 31: 1087-1088. PMID: 40316141, DOI: 10.1016/j.eprac.2025.04.019.Peer-Reviewed Original Research
2024
Analysis of Online Crowdfunding Among Patients Pursuing Metabolic and Bariatric Surgery in the United States
Hamid S, Graetz E, Bakkila B, Chao G, Zolfaghari E, Schultz K, Chetty A, Trabilsy M, Schneider E, Gibbs K. Analysis of Online Crowdfunding Among Patients Pursuing Metabolic and Bariatric Surgery in the United States. Obesity Surgery 2024, 35: 170-180. PMID: 39633092, DOI: 10.1007/s11695-024-07605-7.Peer-Reviewed Original ResearchBariatric surgeryNon-medical expensesRoux-en-Y gastric bypassNon-surgical attemptsRoux-en-YObesity-associated diseasesSleeve gastrectomyGastric bypassBiliopancreatic diversionDuodenal switchAssessed associationsLogistic regressionSurgeryIQRPatientsMedianDiseaseLost wagesHealth-related diseasesUnmet financial needsEligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity
Chetty A, Khunte M, Chen A, Jastreboff A, Krumholz H, Lu Y. Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity. Journal Of General Internal Medicine 2024, 40: 1467-1469. PMID: 39477867, PMCID: PMC12045892, DOI: 10.1007/s11606-024-09178-8.Peer-Reviewed Original Research
2023
A Review of Incretin Therapies Approved and in Late-Stage Development for Overweight and Obesity Management
Chetty A, Rafi E, Bellini N, Buchholz N, Isaacs D. A Review of Incretin Therapies Approved and in Late-Stage Development for Overweight and Obesity Management. Endocrine Practice 2023, 30: 292-303. PMID: 38122931, DOI: 10.1016/j.eprac.2023.12.010.Peer-Reviewed Original ResearchConceptsWeight-related complicationsGlucose-dependent insulinotropic polypeptideReceptor agonistsIncretin therapiesGlucagon-like peptide-1Weight managementObesity managementLate-stage developmentOral GLP-1 receptor agonistSide effectsAssociated with weight regainReview clinical trial dataGLP-1 receptor agonistsDual GLP-1/GIP receptor agonistsGLP-1/GIP receptor agonistsWeeks of treatmentGastrointestinal side effectsClinical trial dataLevels of weight lossWeight reductionCombination therapyWeight regainClinical trialsTherapyPeptide-1
2022
Use of Continuous Glucose Monitoring in Older Adults: A Review of Benefits, Challenges and Future Directions
Prasad-Reddy L, Godina A, Chetty A, Isaacs D. Use of Continuous Glucose Monitoring in Older Adults: A Review of Benefits, Challenges and Future Directions. TouchREVIEWS In Endocrinology 2022, 18: 116-121. PMID: 36694891, PMCID: PMC9835808, DOI: 10.17925/ee.2022.18.2.116.Peer-Reviewed Original ResearchOlder adultsContinuous glucose monitoringEnhance quality of lifeImplementation of continuous glucose monitorsBurden of diabetesImprove glycaemic outcomesQuality of lifeGlucose monitoringStandard of careEffectiveness of continuous glucose monitoringBenefits of continuous glucose monitoringReimbursement barriersImprove glycaemic managementVulnerable populationsHypo-glycaemiaClinical studiesGlycaemic outcomesEnhance qualityReview of benefits
News
News
- August 25, 2025
Examining the Impact of Treating and Preventing Obesity to Prevent Obesity-Related Conditions
- August 04, 2025
New Research Letter Examines GLP-1 Access for Adolescents and Young Adults
- February 19, 2025
New Study Finds Online Advertising for Compounded Diabetes and Weight-Loss Drugs May Mislead Consumers
- May 10, 2024
Inaugural Competition for the Kalanithi Cup Builds Community